Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL000873

Drug Information
NameLurasidone hydrochloride    
Synonyms441351-20-8; SM 13496; Lurasidone hydrochloride; Lurasidone HCl; 367514-88-3; MK-3756; D04820; SMP-13496; N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide; SM-13496; Lurasidone hydrochloride (USAN)    
CompanySumitomo    
IndicationSchizophreniaPhase III completed    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
CAS NumberCAS 367514-87-2
FormularC28H37ClN4O2S    
PubChem Compound IDCID 11237860.    
PubChem Substance IDSID 16321835.    
ClinicalTrials.govNCT00711269;    
Target5-hydroxytryptamine receptor 2A Antagonist[1]
5-hydroxytryptamine receptor 2A Multitarget[1]
D(2) dopamine receptorAntagonist[1]
D(2) dopamine receptorMultitarget[1]
Ref 1The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543